Octagon Capital Partners
Independent Canadian investment dealer
Business Model:
Revenue: $11.2M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Octagon Capital Partners Information
Geographic Data
Address: 170 University Ave Suite 1000
City: Toronto
State: ontario
Zip: M5H 3B3
Country: CA
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Facebook
Twitter
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Octagon Capital Corporation is an independent Canadian investment dealer providing opportunities and advice to institutional investors and corporate clients. Octagon is strategically comprised of intelligent, motivated, successful individuals from diverse, complimentary backgrounds, who work together as a capital markets team to provide the highest level of service to their clients.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 6/2020 | 4D Molecular Therapeutics | Series C | 0 |
| 3/2021 | Bioheng | Series B | 79.7M |
| 2/2010 | SinoHub | Venture Round | 4.6M |
| 2/2021 | Cullgen | Series B | 0 |
| 12/2020 | Immvira | Series C | - |
| 9/2020 | Sonoma Pharmaceuticals | Post-IPO Equity | 70M |
| 6/2021 | Biocytogen | Series E | - |
| 9/2020 | Sonoma BioTherapeutics | Series A | 0 |
| 7/2020 | Harbour Biomed | Series C | 0 |
| 9/2020 | I-Mab Biopharma | Post-IPO Equity | 0 |
| 6/2020 | Everest Medicines | Series C | 310M |
| 2/2012 | Labrador Iron Mines | Post-IPO Equity | 0 |
| 3/2021 | Century Therapeutics | Series C | 0 |
| 1/2021 | Vera Therapeutics | Series C | 0 |
| 8/2021 | Sonoma BioTherapeutics | Series B | 0 |
| 8/2021 | Abogen Biosciences | Series C | 0 |
| 8/2020 | Taysha Gene Therapies | Series B | 0 |
| 7/2020 | New Horizon Health | Series E | 30M |
| 7/2021 | Undercover Snacks | Venture Round | 0 |
| 8/2021 | Abogen Biosciences | Series C | 0 |
| 8/2021 | Sonoma BioTherapeutics | Series B | 0 |
| 7/2021 | Undercover Snacks | Venture Round | 0 |
| 6/2021 | Biocytogen | Series E | - |
| 3/2021 | Bioheng | Series B | 0 |
| 3/2021 | Century Therapeutics | Series C | 0 |
| 2/2021 | Cullgen | Series B | 0 |
| 1/2021 | Vera Therapeutics | Series C | 0 |
| 12/2020 | Immvira | Series C | - |
| 9/2020 | Sonoma BioTherapeutics | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
